HomeNewsIndiaCoronavirus impact | 83 lakh NREGA job cards issued since lockdown, maximum in Uttar Pradesh

Coronavirus impact | 83 lakh NREGA job cards issued since lockdown, maximum in Uttar Pradesh

Between April 1 and September 3, the Centre has issued new NREGA job cards to more than 83 lakh rural households under the MNGREGA scheme, whereas 64.70 lakh new job cards were issued in the last financial year.

September 04, 2020 / 22:02 IST
Story continues below Advertisement
Representative Image
Representative Image

The Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA) social security scheme that guarantees 100 days' wage employment to rural households has emerged as the saviour during the economic crisis brought about by the coronavirus pandemic outbreak.

How do we know that? Since the time stringent coronavirus lockdown measures were imposed, the Centre has issued new NREGA job cards to more than 83 lakh rural households under the MNGREGA scheme. The highest number of these NREGA job guarantee cards were issued to households in Uttar Pradesh, reported The Indian Express.

Story continues below Advertisement

The initial days of the coronavirus lockdown saw a mass migration of daily wage labourers and other migrant workers from the cities to their native villages, as the pandemic practically rendered them jobless.

Since then – from April 1 to September 3 – there has been an unprecedented surge in NREGA beneficiaries. The spike in the number of beneficiaries in this period has been higher than the annual surge recorded for the past seven years. There has been a 28.32 percent rise in the number of beneficiaries as the number of new job cards issued by the government in the last financial year stood at 64.70 lakh.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show